Successful Treatment of Scleredema Diabeticorum With Tranilast: Three Case Reports-Reference-Cited by-同舟云学术

Successful Treatment of Scleredema Diabeticorum With Tranilast: Three Case Reports

Published:2018-01-26 Issue:4 Volume:41 Page:e40-e41
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Sun Min^ORCID,Yang Feng,Hou Maihua^ORCID

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference4 articles.

1. Improvement in Clinical Symptoms of Scleredema Diabeticorum by Frequency-Modulated Electromagnetic Neural Stimulation: A Case Report

2. Regulation of type I collagen and interstitial collagenase mRNA expression in human dermal fibroblasts by colchicine and D-penicillamine;Chung;Yonsei Med J,1999

3. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts;Yamada;J Biochem,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Mucinoses;Rook's Textbook of Dermatology;2024-03-19

2. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema;Journal of the European Academy of Dermatology and Venereology;2024-03-08

3. The key role of organic anion transporter 3 in the drug–drug interaction between tranilast and methotrexate;Journal of Biochemical and Molecular Toxicology;2022-01-12

4. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19;Immunopharmacology and Immunotoxicology;2021-05-04

5. Escleredema diabeticorum: descripción de 11 casos;Medicina Clínica;2020-05